Amgen Quarterly Revenue Rises 6%, Profit Beats Street Estimates
The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects a deal to acquire Horizon Therapeutics to close by mid-December.
Source: medscape.com